Cargando…

Disease Activity Is More Associated with IL-1 Than with IL-6 in Patients with Rheumatoid Arthritis

Interleukin-1 receptor antagonist (IL-1ra) concentration reflects and is proportional to IL-1 production. Both IL-1 and IL-6 are involved in the pathogenesis of rheumatoid arthritis (RA). However, the relationship of serum levels of these two cytokines to each other in RA patients is not well-unders...

Descripción completa

Detalles Bibliográficos
Autores principales:	Almeida-Santiago, Cristina, Quevedo-Abeledo, Juan Carlos, Hernández-Hernández, María Vanesa, de Vera-González, Antonia, González-Delgado, Alejandra, González-Gay, Miguel Ángel, Ferraz-Amaro, Iván
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9862960/ https://www.ncbi.nlm.nih.gov/pubmed/36676031 http://dx.doi.org/10.3390/life13010082

Ejemplares similares

Interleukin 1 receptor antagonist relation to cardiovascular disease risk in patients with rheumatoid arthritis
por: Almeida-Santiago, Cristina, et al.
Publicado: (2022)

The angiopoietin-like protein 4, apolipoprotein C3, and lipoprotein lipase axis is disrupted in patients with rheumatoid arthritis
por: de Armas-Rillo, Laura, et al.
Publicado: (2022)

Relationship of Blood Inflammatory Composite Markers with Cardiovascular Risk Factors and Subclinical Atherosclerosis in Patients with Rheumatoid Arthritis
por: González-Sierra, Marta, et al.
Publicado: (2023)

Apolipoprotein C-III is linked to the insulin resistance and beta-cell dysfunction that are present in rheumatoid arthritis
por: Martín-González, Candelaria, et al.
Publicado: (2022)

Red Cell Distribution Width Association with Subclinical Cardiovascular Disease in Patients with Rheumatoid Arthritis
por: González-Sierra, Marta, et al.
Publicado: (2023)

The Ratio of Monocytes to HDL-Cholesterol Is Associated with Cardiovascular Risk and Insulin Resistance in Patients with Rheumatoid Arthritis
por: Romo-Cordero, Alejandro, et al.
Publicado: (2023)

Mean Platelet Volume in a Series of 315 Patients with Rheumatoid Arthritis: Relationship with Disease Characteristics, including Subclinical Atherosclerosis and Cardiovascular Comorbidity
por: González-Sierra, Marta, et al.
Publicado: (2023)

Incretins in patients with rheumatoid arthritis
por: Tejera-Segura, Beatriz, et al.
Publicado: (2017)

The Performance of Vascular Age in the Assessment of Cardiovascular Risk of Patients with Rheumatoid Arthritis
por: Ferraz-Amaro, Iván, et al.
Publicado: (2020)

Disease activity influences the reclassification of rheumatoid arthritis into very high cardiovascular risk
por: Ferraz-Amaro, Iván, et al.
Publicado: (2021)

SCORE2 Assessment in the Calculation of Cardiovascular Risk in Patients with Rheumatoid Arthritis
por: Ferraz-Amaro, Iván, et al.
Publicado: (2021)

Apolipoprotein C-III in patients with systemic lupus erythematosus
por: Martín-González, Candelaria, et al.
Publicado: (2022)

Key Molecules of Triglycerides Pathway Metabolism Are Disturbed in Patients With Systemic Lupus Erythematosus
por: Quevedo-Abeledo, Juan Carlos, et al.
Publicado: (2022)

SCORE2 versus SCORE in patients with systemic lupus erythematosus
por: Quevedo-Abeledo, Juan Carlos, et al.
Publicado: (2022)

Correction: Ferraz-Amaro et al. SCORE2 Assessment in The Calculation of Cardiovascular Risk in Patients with Rheumatoid Arthritis. Diagnostics 2021, 11, 2363
por: Ferraz-Amaro, Iván, et al.
Publicado: (2022)

Relationship between Disease Characteristics and Circulating Interleukin 6 in a Well-Characterized Cohort of Patients with Systemic Lupus Erythematosus
por: Mercader-Salvans, Julia, et al.
Publicado: (2023)

Metabolic Syndrome in Rheumatoid Arthritis
por: Ferraz-Amaro, Iván, et al.
Publicado: (2013)

HDL cholesterol efflux capacity in rheumatoid arthritis patients: contributing factors and relationship with subclinical atherosclerosis
por: Tejera-Segura, Beatriz, et al.
Publicado: (2017)

IL-15 and its role in rheumatoid arthritis
por: Kurowska-Stolarska, M, et al.
Publicado: (2003)

Vascular Endothelial Growth Factor and Its Soluble Receptor in Systemic Lupus Erythematosus Patients
por: Gómez-Bernal, Fuensanta, et al.
Publicado: (2022)

Serum Levels of Transforming Growth Factor Beta 1 in Systemic Lupus Erythematosus Patients
por: Gómez-Bernal, Fuensanta, et al.
Publicado: (2022)

Impaired beta cell function is present in nondiabetic rheumatoid arthritis patients
por: Ferraz-Amaro, Iván, et al.
Publicado: (2013)

Relationship between Malondialdehyde Serum Levels and Disease Features in a Full Characterized Series of 284 Patients with Systemic Lupus Erythematosus
por: Merino de Paz, Nayra, et al.
Publicado: (2023)

The Novel Role of MIF in the Secretion of IL-25, IL-31, and IL-33 from PBMC of Patients with Rheumatoid Arthritis
por: García-Arellano, Samuel, et al.
Publicado: (2021)

Transforming growth factor beta 1 is associated with subclinical carotid atherosclerosis in patients with systemic lupus erythematosus
por: Gómez-Bernal, Fuensanta, et al.
Publicado: (2023)

Relationship of Fibroblast Growth Factor 23 Serum Levels with Disease Characteristics in Systemic Lupus Erythematosus Patients
por: Fernández-Cladera, Yolanda, et al.
Publicado: (2023)

Full characterization of the three pathways of the complement system in patients with systemic lupus erythematosus
por: García-González, María, et al.
Publicado: (2023)

IL-17, synoviolin and rheumatoid arthritis chronicity
por: Miossec, Pierre
Publicado: (2012)

IL-26 Kick-Starts Rheumatoid Arthritis
por: Sedwick, Caitlin
Publicado: (2012)

Circulating levels of IL-7 in rheumatoid arthritis
por: Churchman, S, et al.
Publicado: (2007)

Promotion of osteoclastogenesis by IL-26 in rheumatoid arthritis
por: Lee, Kyung-Ann, et al.
Publicado: (2019)

Pathogenic roles of IL-6 and IL-6 blocking therapy on rheumatoid arthritis
por: Yoshizaki, K, et al.
Publicado: (2003)

HDL Cholesterol Efflux and the Complement System Are Linked in Systemic Lupus Erythematosus
por: García-González, María, et al.
Publicado: (2023)

Decreased response to IL-12 and IL-18 of peripheral blood cells in rheumatoid arthritis
por: Kawashima, Masanori, et al.
Publicado: (2004)

IL-1 but not IL-18 induces osteoprotegerin and TRAIL in rheumatoid arthritis synovial fibroblasts
por: Morel, J, et al.
Publicado: (2003)

IL-32 and IL-17 interact and have the potential to aggravate osteoclastogenesis in rheumatoid arthritis
por: Moon, Young-Mee, et al.
Publicado: (2012)

IL17A and IL17F gene polymorphisms in patients with rheumatoid arthritis
por: Pawlik, Andrzej, et al.
Publicado: (2016)

The Relationship of Cytokines IL-13 and IL-17 with Autoantibodies Profile in Early Rheumatoid Arthritis
por: Siloşi, Isabela, et al.
Publicado: (2016)

Proprotein convertase subtilisin/kexin type 9 is related to disease activity and damage in patients with systemic erythematosus lupus
por: Sánchez-Pérez, Hiurma, et al.
Publicado: (2020)

Analysis of IL-10 gene variants in rheumatoid arthritis
por: Huizinga, T, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_uvf7shnmv7sjpot5n5oprcnt9l